Clinical Trials

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University